MICROBOT MEDICAL INC. Payments to Acquire Held-to-maturity Securities
MICROBOT MEDICAL INC. (MBOT) reported Payments to Acquire Held-to-maturity Securities of $82.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2026-03-26
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for the quarter ending 2025-12-31 was $3.01M.
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for the quarter ending 2025-09-30 was $48.00M.
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for the quarter ending 2025-06-30 was $3.80M.
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for the quarter ending 2025-03-31 was $28.12M, a 449.18% increase year-over-year.
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for fiscal 2025 was $82.93M, a 1519.65% increase from fiscal 2024.
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for fiscal 2024 was $5.12M, a 49.11% decline from fiscal 2023.
- MICROBOT MEDICAL INC. payments to acquire held-to-maturity securities for fiscal 2023 was $10.06M.
| Period end | Payments to Acquire Held-to-maturity Securities 3 month | Payments to Acquire Held-to-maturity Securities 6 month | Payments to Acquire Held-to-maturity Securities 9 month | Payments to Acquire Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $51.01M derived: sum of 2 quarters · filed 2026-03-26 | $54.81M derived: sum of 3 quarters · filed 2026-03-26 | $82.93M 10-K · filed 2026-03-26 |
| 2025-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $51.80M derived: sum of 2 quarters · filed 2025-11-12 | $79.92M 10-Q · filed 2025-11-12 | $79.92M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $31.92M 10-Q · filed 2025-08-12 | $31.92M derived: sum of 3 quarters · filed 2026-03-26 | $31.92M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $28.12M 10-Q · filed 2025-05-14 | $28.12M derived: sum of 2 quarters · filed 2026-03-26 | $28.12M derived: sum of 3 quarters · filed 2026-03-26 | $28.12M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | $5.12M 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $5.12M 10-Q · filed 2025-11-12 | $6.80M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $5.12M 10-Q · filed 2025-08-12 | $6.80M derived: sum of 3 quarters · filed 2025-08-12 | $11.99M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $5.12M 10-Q · filed 2025-05-14 | $6.80M derived: sum of 2 quarters · filed 2025-05-14 | $11.99M derived: sum of 3 quarters · filed 2025-05-14 | $14.54M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $6.87M derived: sum of 2 quarters · filed 2025-03-25 | $9.42M derived: sum of 3 quarters · filed 2025-03-25 | $10.06M 10-K · filed 2025-03-25 |
| 2023-09-30 | $5.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $7.74M derived: sum of 2 quarters · filed 2024-11-13 | $8.38M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $3.19M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $638.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |